版本:
中国

BRIEF-Versartis reports new data on Somavaratan in growth hormone deficiency

April 3 Versartis Inc

* Versartis reports new data on long-acting Somavaratan in growth hormone deficiency at endo 2017

* Baseline characteristics of phase 3 velocity trial population balanced between study arms and comparable to phase 2

* Further results from vital trial in adult ghd-similar Somavaratan PK/PD data in U.S., Japanese children support using same dose in ongoing phase 3 trials Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐